How Agencies Plan to Survive Pharmageddon


With a host of big-spending blockbuster medications about to lose patent protection and fewer new prescription remedies queued up to take their place, the ad industry clearly has a drug problem.

No Responses to “How Agencies Plan to Survive Pharmageddon”

Post a Comment